IOSP
InnospecADocument history
Earnings documents stored for IOSP.
Investor releaseQuarter not tagged2026-05-13Innospec Q1 Earnings Beat Estimates, Sales Rise Y/Y On FX Tailwinds
Zacks
Innospec Q1 Earnings Beat Estimates, Sales Rise Y/Y On FX Tailwinds
Innospec Inc. IOSP earnings per share (as reported) for the first quarter of 2026 declined to $1.22 per share from $1.31 a year ago. Adjusted earnings per share declined 26% to $1.05 per share from $1.42 a year ago. It beat the Zacks Consensus Estimate of $1.02 per share. Revenues for the first quarter rose 3% year over year to $453.2 million, beating the Zacks Consensus Estimate of $432.2 million. Adjusted EBITDA declined 19% year over year to $43.7 million. Operating income declined 14% to $36.5 million. Innospec Inc. price-consensus-eps-surprise-chart | Innospec Inc. Quote Fuel Specialties revenues rose 7% year over year to $181.6 million, driven by volume growth of 10% and a favorable currency impact of 6%, offset by an adverse price/mix of 9%. Gross margin compressed 0.3 percentage points to 35.4% and operating income increased 2% to $37.8 million. Performance Chemicals revenues rose 1% to $169.4 million as volume declines of 9% were offset by positive price/mix of 1% and favorable currency impact of 9%. Gross margin declined 4.2 percentage points to 16.8% and operating income fell 46% to $10.7 million, adversely impacted by shutdowns at the North Carolina plants due to the January 2026 U.S. winter storm. Oilfield Services revenues were essentially flat at $102.2 million. Gross margin improved 1.7 percentage points to 30.1% on a richer sales mix, and operating income increased 37% to $5.6 million, although results were also negatively impacted by the winter storm. Operating cash flow was $17.6 million versus $28.3 million in the year-ago quarter. The company ended the quarter with cash of $289.1 million and no debt. In the first quarter, the effective tax rate was 22.8% compared with 25.7% in the year-ago quarter. The company increased its semi-annual dividend by 10% to 92 cents per share, repurchased $6.2 million of shares in the quarter and announced a new $75 million buyback authorization. Management expects sequential growth in the second quarter from Performance Chemicals, supported by plant repairs, pricing/mix opportunities and margin initiatives. For Oilfield Services, the company remains cautiously optimistic that recent DRA expansion and opportunities in completions and production will drive sequential improvement in the second quarter and position the business for further improvement in the second half of 2026. Fuel Specialties is expected to...
Investor releaseQuarter not tagged2026-05-08Innospec Q1 Earnings Call Highlights
MarketBeat
Innospec Q1 Earnings Call Highlights
Interested in Innospec Inc.? Here are five stocks we like better. Innospec reported mixed Q1 results: total revenue rose 3% to $453.2M, but adjusted EBITDA fell to $43.7M and adjusted EPS dropped to $1.05 (from $1.42), with overall gross margin down to 27.3% driven by segment mix and disruptions. The January U.S. winter storm forced shutdowns in Performance Chemicals, causing a 9% volume decline, gross margin slump to 16.8% (from 21.0%) and a 46% drop in operating income to $10.7M; management is prioritizing repairs and plant optimizations and expects sequential improvement in Q2 and a stronger recovery in Q3. Fuel Specialties posted growth (revenue +7%, volume +10%) but may face near-term margin compression from crude-derived raw material inflation, while Oilfield Services improved margins; the company remains debt-free with $289.1M cash, a 10% dividend increase and a $75M share buyback program. Innospec (NASDAQ:IOSP) reported mixed first-quarter 2026 results, as strong performance in its Fuel Specialties segment was partially offset by disruptions tied to a January 2026 U.S. winter storm that affected operations in Performance Chemicals and, to a lesser extent, Oilfield Services. Management also discussed the potential impacts of geopolitical disruptions, including the Middle East conflict, on raw materials, customer activity, and near-term margins. Executive Vice President and Chief Financial Officer Ian Cleminson said total revenues in the first quarter were $453.2 million, up 3% from $440.8 million a year earlier. Overall gross margin decreased 1.1 percentage points year over year to 27.3%. → Insider Sales: Top AST SpaceMobile Insider Cuts Postion Over 30% Adjusted EBITDA was $43.7 million compared with $54.0 million in the prior-year quarter. Net income attributable to Innospec was $30.4 million versus $32.8 million a year ago. GAAP earnings per share were $1.22, including special items that increased earnings by $0.17 per share. On an adjusted basis, EPS was $1.05 compared with $1.42 a year earlier. President and CEO Patrick Williams said Performance Chemicals results were significantly affected by the shutdown of the company’s North Carolina plants due to the winter storm. He added that the company is prioritizing repairs “in order to meet customer requirements,” while also pulling forward “multiple plant optimization projects which will drive long-t...
Investor releaseQuarter not tagged2026-05-08Innospec (IOSP) Surpasses Q1 Earnings and Revenue Estimates
Zacks
Innospec (IOSP) Surpasses Q1 Earnings and Revenue Estimates
Innospec (IOSP) came out with quarterly earnings of $1.05 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $1.42 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +3.45%. A quarter ago, it was expected that this specialty chemicals company would post earnings of $1.26 per share when it actually produced earnings of $1.5, delivering a surprise of +19.05%. Over the last four quarters, the company has surpassed consensus EPS estimates four times. Innospec, which belongs to the Zacks Chemical - Diversified industry, posted revenues of $453.2 million for the quarter ended March 2026, surpassing the Zacks Consensus Estimate by 4.87%. This compares to year-ago revenues of $440.8 million. The company has topped consensus revenue estimates three times over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Innospec shares have added about 1.5% since the beginning of the year versus the S&P 500's gain of 7.6%. While Innospec has underperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Innospec was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #4 (Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 Rank (Strong B...
Investor releaseQuarter not tagged2026-05-08Innospec Reports First Quarter 2026 Financial Results
GlobeNewswire
Innospec Reports First Quarter 2026 Financial Results
Continued strength in Fuel Specialties offset negative US winter storm impacts in other businesses Increasing confidence for sequential operating income and margin growth in Performance Chemicals and Oilfield Services Dividend increased by 10 percent; $6.2 million in share repurchases made in the quarter New $75 million buyback authorization GAAP EPS of $1.22 and adjusted non-GAAP EPS of $1.05 ENGLEWOOD, Colo., May 07, 2026 (GLOBE NEWSWIRE) -- Innospec Inc. (NASDAQ: IOSP) today announced its financial results for the first quarter ended March 31, 2026. The Company declared its semi-annual dividend of 92 cents per common share for the first half of this year, representing an increase of 10 percent. This dividend will be paid on May 29, 2026 to shareholders of record on May 19, 2026. Total revenues for the first quarter were $453.2 million, an increase of 3 percent from $440.8 million in the corresponding period last year. Net income attributable to Innospec for the quarter was $30.4 million or $1.22 per diluted share compared to $32.8 million or $1.31 per diluted share recorded in the corresponding period last year. Adjusted EBITDA for the quarter was $43.7 million compared to $54.0 million reported in the same period a year ago. Results for this quarter include some special items, which are summarized in the table below. Excluding these items, adjusted non-GAAP EPS in the first quarter was $1.05 per diluted share, compared to $1.42 per diluted share a year ago. Cash from operating activities was $17.6 million before capital expenditures of $8.6 million. The quarter closed with net cash of $289.1 million. Adjusted EBITDA and net income attributable to Innospec excluding special items, and related per-share amounts, together with net cash, are non-GAAP financial measures that are defined and reconciled with GAAP results herein and in the schedules below. Commenting on the first quarter results, Patrick S. Williams, President and Chief Executive Officer, said, “This was a mixed quarter for Innospec with continued strong results in Fuel Specialties partially offsetting the negative impacts of the January 2026 US winter storm on Performance Chemicals and Oilfield Services. Performance Chemicals sales were broadly flat with last year, but margins and operating income were significantly impacted by a shutdown of the North Carolina plants due to the US winter storm....
Investor releaseQuarter not tagged2026-05-08Innospec: Q1 Earnings Snapshot
Associated Press
Innospec: Q1 Earnings Snapshot
ENGLEWOOD, Colo. (AP) — ENGLEWOOD, Colo. (AP) — Innospec Inc. (IOSP) on Thursday reported earnings of $30.4 million in its first quarter. On a per-share basis, the Englewood, Colorado-based company said it had profit of $1.22. Earnings, adjusted for non-recurring gains, came to $1.05 per share. The specialty chemicals company posted revenue of $453.2 million in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IOSP at https://www.zacks.com/ap/IOSP
Investor releaseQuarter not tagged2026-05-08Innospec (IOSP) Q1 2026 Earnings Transcript
Motley Fool
Innospec (IOSP) Q1 2026 Earnings Transcript
Image source: The Motley Fool. Friday, May 8, 2026 at 9 a.m. ET President and Chief Executive Officer — Patrick Williams Executive Vice President and Chief Financial Officer — Ian Cleminson Patrick Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer. With that, I will turn it over to you, Patrick. Patrick Williams: Thank you, David, and welcome, everyone, to Innospec Inc.'s first quarter 2026 conference call. Before discussing the results, I want to recognize the focus and determination being demonstrated by our employees around the world, and especially those in the Middle East. Volatile environments like this bring a unique set of challenges and opportunities. We are seeing increased chances to deliver innovative solutions and security of supply to all our customers, and we continue to execute on these initiatives. This was a mixed quarter for Innospec Inc., with continued strong results in Fuel Specialties partially offsetting the impacts of the January 2026 U.S. winter storm, which affected Performance Chemicals and Oilfield Services. Performance Chemicals sales were broadly flat with last year, but margins and operating income were significantly impacted by the shutdown of our North Carolina plants due to the U.S. winter storm. We are continuing to prioritize plant repairs in order to meet customer requirements. Additionally, and without slowing the pace of these critical plant repairs, we have elected to pull forward multiple plant optimization projects which will drive long-term benefits. In parallel, we continue to execute on a range of top-line and margin opportunities identified in the business which we expect to drive sequential growth in the second quarter. Fuel Specialties had another strong quarter with sales growth and margins that remained at the upper end of our target range. The business has continued to deliver consistent strong results through a range of economic cycles. With a diverse pipeline and a number of non-fuel opportunities across all regions, we expect a continued strong performance in this business. Oilfield Services operating income and margins improved on the prior year, but sequential results were impacted by the U.S. winter storm. While the Middle East conflict may delay some activity in the region, it is also creating new opportunities that we are aggress...
Investor releaseQuarter not tagged2026-05-08Innospec Inc. Q1 2026 Earnings Call Summary
Moby
Innospec Inc. Q1 2026 Earnings Call Summary
Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you invest and we'll show you why it's our #1 pick. Tap here. Performance was significantly impacted by a January 2026 U.S. winter storm that forced shutdowns at North Carolina plants; while this led to a 9% volume decline in Performance Chemicals and hit margins, Oilfield Services revenue remained flat and order patterns across the business remain extremely strong. Management elected to pull forward multiple plant optimization projects during storm-related repairs to drive long-term yield, efficiency, and automation benefits. Performance Chemicals saw a 9% volume decline due to manufacturing constraints, though management notes that order patterns remain extremely strong. Fuel Specialties delivered a strong quarter with 10% volume growth, which was largely offset by a 9% negative price/mix. Performance was driven by market share gains and expansion into adjacent non-fuel markets like polyethylene and polypropylene. Oilfield Services margins improved year-over-year due to a better sales mix and the recent Drag Reducing Agents (DRA) expansion, despite sequential weather headwinds. Geopolitical volatility in the Middle East is creating a 'security of supply' premium, allowing Innospec to capture new opportunities in heavy crude and pipeline logistics. The company maintains a debt-free balance sheet with 289.1 million dollars in cash, providing flexibility for a 10% dividend increase and a new 75 million dollars buyback. Management expects sequential operating income growth in Performance Chemicals and Oilfield Services for Q2, with more significant improvements anticipated in the second half of 2026. Fuel Specialties is expected to face some gross margin compression and a sequential decline in operating income in Q2 due to seasonal impacts and the time lag in raw material cost pass-through mechanisms. The DRA plant expansion is projected to be near maximum capacity during the second and fourth quarters of 2026 to meet rising demand. Q2 earnings per share are anticipated to be similar to Q1 levels, potentially increasing by a penny or two as recovery efforts continue. Management has currently slowed M&A activity but intends to aggressively pursue deals once a financial turnaround in Performance Chemicals is reflected in the results, ideally by the third quarter. The U.S....
TranscriptFY2026 Q12026-05-08FY2026 Q1 earnings call transcript
Earnings source - 66 paragraphs
FY2026 Q1 earnings call transcript
Good day, and thank you for standing by. Welcome to the Innospec's first quarter 2026 earnings release and conference call. At this time, all participants are in listen only mode. After the speaker's presentation, there will be the question-and-answer session. To ask a question during the session, you need to press star one one on your telephone keypad. You will hear an automatic message advising your hand is raised. To withdraw your question, please press star one and one again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to our first speaker today, David Jones, General Counsel and Chief Compliance Officer. Please go ahead, sir.
Thank you. Welcome to Innospec's first quarter earnings call. It's David Jones. I'm Innospec's General Counsel and Chief Compliance Officer. The earnings release for the quarter and this presentation are posted on the company's website. During this call, we will make forward-looking statements which are predictions about future events. These statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ from the anticipated results implied by such forward-looking statements. These risks and uncertainties are detailed in Innospec's 10-K, 10-Qs, and other filings with the SEC. Please see the SEC site and Innospec's site for these and related documents. In today's presentation, we've also included non-GAAP financial measures. A reconciliation to the most directly comparable GAAP financial measure is contained in the earnings release.
Non-GAAP financial measures should not be considered as a substitute for or superior to those prepared in accordance with GAAP. They're included to aid investor understanding of the company's performance in addition to the impact that these items and events had on financial results. With me today from Innospec are Patrick Williams, President and Chief Executive Officer, and Ian Cleminson, Executive Vice President and Chief Financial Officer. With that, I turn it over to you, Patrick.
Thank you, David, and welcome everyone to Innospec's first quarter 2026 conference call. Before discussing the results, I want to recognize the focus and determination being demonstrated by our employees around the world and especially those in the Middle East. Volatile environments like this bring a unique set of challenges and opportunities. We are seeing increased chances to deliver innovative solutions and security of supply to all our customers. We will continue to execute on these initiatives. This was a mixed quarter for Innospec with continued strong results in Fuel Specialties, partially offsetting the impacts of the January 2026 U.S. winter storm, which affected Performance Chemicals and Oilfield Services. Performance Chemicals sales were broadly flat with last year. Margins and operating income were significantly impacted by the shutdown of our North Carolina plants due to the U.S. winter storm.
We are continuing to prioritize plant repairs in order to meet customer requirements. Additionally, and without slowing the pace of these critical plant repairs, we have elected to pull forward multiple plant optimization projects which will drive long-term benefits. In parallel, we continue to execute on a range of top-line and margin opportunities identified in the business, which we expect to drive sequential growth in the second quarter. Fuel Specialties had another strong quarter with sales growth and margins that remained at the upper end of our target range. The business has continued to deliver consistent strong results through a range of economic cycles. With a diverse pipeline and of non-fuel opportunities across all regions, we expect a continued strong performance in this business. Oilfield Services operating income and margins improved on the prior year, but sequential results were impacted by the U.S. winter storm.
While the Middle East conflict may delay some activity in the region, it is also creating new opportunities which we are aggressively pursuing. In parallel, we remain focused on driving incremental growth from our recent DRA expansion and other opportunities in our completions and production segments. We are cautiously optimistic that this combination will deliver sequential operating improvement in the 2nd quarter and leave us well positioned for further improvement in the 2nd half of 2026. I will turn the call over to Ian Cleminson, who will review our financial results in more detail. I will return with some concluding comments. After that, Ian and I will take your questions. Ian?
Thanks, Patrick. Turning to slide 7 in the presentation, the company's total revenues for the first quarter were $453.2 million, a 3% increase from $440.8 million a year ago. Overall gross margin decreased by 1.1 percentage points from last year to 27.3%. Adjusted EBITDA for the quarter was $43.7 million compared to $54 million last year, and net income attributable to Innospec for the quarter was $30.4 million compared to $32.8 million a year ago. Our GAAP earnings per share were $1.22, including special items, the net effect of which increased our first quarter earnings by $0.17 per share.
A year ago, we reported GAAP earnings per share of $1.31, which included a negative impact from special items of $0.11 per share. Excluding special items in both years, our Adjusted EPS for the quarter was $1.05 compared to $1.42 a year ago. Turning to slide 8. Revenues in Performance Chemicals for the first quarter were $169.4 million, up 1% from last year's $168.4 million. Volume reductions of 9% were offset by a positive price mix of 1% and a favorable currency impact of 9%. Gross margins of 16.8% decreased 4.2 percentage points compared to the 21% in the same quarter in 2025 due to the impact of the U.S. winter storm at the start of the quarter.
Operating income of $10.7 million decreased 46% from $19.8 million last year. Moving on to slide 9. Revenues in Fuel Specialties for the first quarter were $181.6 million, up 7% from the $170.3 million reported a year ago. A 10% increase in volumes and a favorable currency impact of 6% were offset by a negative price mix of 9%. Fuel Specialties gross margins of 35.4% were broadly flat with the same quarter last year. Operating income of $37.8 million was up 2% from $36.9 million a year ago. Moving on to slide 10. Revenues in Oilfield Services for the quarter were $102.2 million, flat with the first quarter last year.
Gross margins of 30.1% increased 1.7 percentage points from last year's 28.4% on an improved sales mix. Operating income of $5.6 million increased 37% from $4.1 million a year ago. Turning to slide 11. Corporate costs for the quarter were $22.3 million compared with $17.7 million a year ago, driven by higher legacy costs of closed operations, higher legal and compliance expenses, and additional amortization for our ERP system. The effective tax rate for the quarter was 22.8% compared to 25.7% a year ago. Moving on to slide 12. Cash generated from operating activities was $17.6 million before capital expenditures of $8.6 million. In the 1st quarter, we bought back 90,000 shares at a cost of $6.2 million.
As of March 31st, Innospec had $289.1 million in cash and cash equivalents and no debt. I now turn it back over to Patrick for some final comments. Patrick?
Thanks, Ian. With our diversified global supply chain and manufacturing footprint, we believe that we are well-positioned to manage the direct impacts of near-term geopolitical disruptions. We are monitoring closely the potential for further raw material inflation and supply disruption as the Middle East conflict extends. During this period, we remain focused on our continued commitment to security of supply and innovative solutions for our customers. We will continue to implement improvements across all our businesses that will position us for growth and margin expansion as the market conditions recover. Our short-term expectations is for sequential operating income growth in Performance Chemicals and Oilfield Services and steady performance in Fuel Specialties. Our strong debt-free balance sheet continues to allow for significant flexibility in the current environment to pursue further dividend growth, buybacks, organic investment, and M&A.
Cash generation was again positive this quarter, and our net cash position held at over $289 million after repurchasing 90,000 shares at a cost of $6.2 million. In addition, this quarter, our board approved a further 10% increase in our semiannual dividend to $0.92 per share, which together with the newly announced $75 million buyback, further enhances shareholder returns. Now I will turn the call over to the operator, and he and I will take your questions.
Thank you. Dear participants, as a reminder, if you wish to ask a question, please press star one one on your telephone keypad and wait for a name to be announced. To withdraw your question, please press star one and one again. Please stand by while we compile the Q&A roster. This will take a few moments. Now we're going to take our first question, and it comes to the line of Mike Harrison from Seaport Research Partners. Your line is open. Please ask your question.
Hi, good morning.
Morning, Mike.
Good morning, Mike.
Wanted to just start with the Performance Chemicals business. Maybe help us understand how much of that volume decline was related to the weather or outage impact. I guess what you're seeing in terms of underlying market dynamics there, given the consumer sentiment remains a little bit weak and really just trying to get a sense of you know, should we see volumes start to recover in the second quarter? Is that more of a second-half type of dynamic?
Yeah, Mike, I'll kind of go in reverse of the question. I think you'll start seeing it in the second half of the year. it's not necessarily orders that we're seeing a negative impact. Our order pattern is very strong right now. The issue we're still having is the plant and that effect from the winter storm that we had early on or late in the season. it's a, it's an issue of getting product out and manufactured and out the door. It's not an issue of orders. you know, I think what you'll see probably is a similar, maybe a little better quarter in Q2 with a significant better increase in Q3. That's where we sit right now. we can give you obviously more color as we go along.
Oh, yeah, just to kind of follow up on that, can you maybe walk us through the repairs and upgrades or optimizations that you're making at the High Point and Salisbury plants in North Carolina? What's happening at each plant? What's the timeline for each plant, I guess, to get fully back up and running? Can you help us understand what the potential benefits are of the optimizations that you're working on?
Number 1 was to get the plant up and running so we could at least, you know, meet most of the orders that we have in place today. The number 1 priority was to get the plant up and running, and we've gotten the majority of that right now. Along the way, we've decided that let's start to optimize to where we get better yields, better efficiencies, automation, et cetera, along the way, the number 1 critical part was to get product to customers. That's been the primary focus. As we move through the stage of that, we're moving back into the stage of automation, et cetera, we just talked about. It's a process. It takes time. You know, you had frozen pipes. We've had to replace a lot of pipes, boilers, et cetera.
There is a timeline on everything that we've done. We have a plan in place. Mike, as you know, when plants go down, it just takes time to get some of these things fixed. As you fix one thing, another thing pops up. It's just taking some time. It's a little frustrating by us, but we are starting to see a light at the end of the tunnel. The good thing is, again, the order pattern is extremely strong. I think when we come out of this, you know, priority number 1 is to get product to customers. Priority number 2 is let's make sure we don't have the problems again, and of course, better efficiency, better yield, better quality, et cetera, which should come along within the latter part of the year.
All right. Very helpful. Then I wanted to move on to just understanding some of the impacts of the Iran war on your business. I think first of all, just from a raw material perspective, I'm a little concerned about the Fuel Specialties business. That business tends to pass through raw material costs on its index, and sometimes there's a lag, I guess. What are you anticipating in terms of some potential margin pressure impacting the Fuel Specialties business? I guess with pricing negative in the quarter, should we assume that that price mix number turns positive again in the second quarter? Is that maybe we see that remain negative and not turn positive until the second half?
Yeah, let me take the first part of that, Mike. Fuel Specialties is a business that operates through or has operated through many different economic cycles, and this, in many ways, is similar to what we've been through before. We've seen some really serious spikes in raw material costs and crude derivatives. You're absolutely spot on, that we have a pass-through mechanism for most of our business, and that does have a time lag. Our expectation is that we'll see some gross margin compression in the second quarter. That's, that's not to be unexpected. Depending on how long some of this continues for, we may well be chasing some of those price increases for a quarter or two. If prices stabilize or drop, we'll obviously see the benefits of that in the fullness of time.
Again, a little bit like Performance Chemicals, demand is really good. The business is operating at the real top end of where we expect it to be. With the seasonal impact of Fuel Specialties in Q2 dropping off a little bit and some tightening of gross margins, we expect operating income to be in that sort of low $32 million-$33 million in the second quarter. A little bit lighter than Q1, but margins potentially a little bit tighter as well.
Yeah, Mike, you know, it's interesting. As Ian said, we've been through these cycles before in this business, and we've managed it extremely well. What you always look for is there demand destruction, right? You see high crude prices, high jet prices, you know, high diesel, gasoline moving up in the marketplace. Will that have demand destruction? We're not seeing it quite yet. You know, it could happen, but typically what you see is a slight demand destruction, but yet the margin profile still stays pretty steady, and this business just kind of marches along. I think as Ian and I looked at this and ascertained the situation and all the market, you know, information that we're getting, still feel very confident that Fuel Specialties will continue on this path.
No, we're, I mean, the market is surprisingly resilient here. I was surprised to see the unemployment numbers that came out today. We'll see what happens with demand. I guess the last question that I had is just, you know, maybe tying it all together, you mentioned the sequential decline in Fuel Specialties and sequential growth expectations for Performance Chems and for Oilfield. Net-net is Q2 earnings pretty similar to Q1, a little bit lower than Q1? Maybe just any additional color you can provide there would be helpful.
Yeah. I'll let Ian take the first part, and I'll add some clarity to it as well.
Yeah. You, you've called it pretty right there, Mike. You know, we're expecting a small drop-off in fuels compared to Q1, seasonally driven. We expect a small increase sequentially in Performance Chemicals and the same in oil field. Net-net, you're gonna come out with a very similar quarter in terms of EPS, maybe $0.01 or $0.02 higher. We do need to see the impacts of the war coming through, but right now, that's how we see it. Very much like it's modeled in your numbers as well, Mike.
Yeah. I think, Mike, you know, we looked at your model and your numbers on, let's talk about Oilfield Services. We haven't touched much on Oilfield Services. You know, where there's chaos, there's opportunities, right? I think if you look at the expansion that we did in DRA, this chaos has created a lot of opportunities in DRA. As Ian said, that will help boost Oilfield Services in Q2 and Q3 moving forward. We're seeing more opportunities with higher crude prices. Even if crude prices come down, we still feel like we're in a better position than we have been in the past. You know, I think as Ian said, you'll see a similar type, little bit of improvement in Q2, and then you'll see the bigger improvements in Q3, Q4.
All right. Very helpful.
I'll turn it back. Thanks.
Thanks, Mike.
Thanks, Mike.
Thank you. Now we're going to take our next question. The question comes line of Jon Tanwanteng from CJS Securities. Your line is open. Please ask the question.
Hey, good morning, and thank you for taking my questions. Patrick, I just wanna drill down on the Oilfield Services, pun intended there. You mentioned you're obviously seeing more opportunities there, even with the delays, you know, and the expansion to the Middle East. Are those net positive opportunities as you look at the full year? Or is it a net negative just with the disruptions that you're seeing, you know, compared to what you thought maybe 2 or 3 months ago?
Yeah. It's definitely, Jon, net positive. I think that what we're seeing is position that we put our product lines in with specific customers, either, A, in the Middle East and even a little bit now potentially in Argentina or Venezuela and Mexico as well, where there's heavy crude. We think these are potentially long-term opportunities. You know, it's, you know, as I said earlier, there's opportunity in chaos, because of our technologies, it's provided us a lot of opportunity. Now it's up for us to capture that. Even as the Straits of Hormuz open up, you have the East-West Pipeline that we're looking at helping out right now with DRA. Once the Straits open up, you'll see fracking pick up again, which will obviously help our business again.
You're seeing Venezuela coming in with heavy crude that we're looking to trade on their heavy crude. A lot of this chaos has created a lot of opportunities. I think if we positioned ourselves properly, we have great technology. Now it's a matter for our group to go ahead and execute. We're starting to see that happening. That's why we're telling you we'll see a sequential improvement over Q1 in Oilfield, and we should see that throughout the rest of the year.
Got it. Thank you. If I could just ask two more on the same topic. Are you seeing any DRA opportunities pushed out of this year as a result of the delays and the conflict, number one? Number two, is there any update on your, you know, prior large Latin American client, and if the, you know, the higher prices today might spur them to do something sooner rather than later?
Yeah. On DRA, we've seen all opportunities. Matter of fact, the plant expansion that we put together is pretty much going to be maxed out in Q2 and Q4. Pure opportunities there. If you look at the Latin America opportunities, and we mentioned a couple, we mentioned Venezuela. I know your specific question is to Mexico. There is activity going in Mexico right now. Obviously, with their heavy crude and where the crude prices are right now, and the need for the Gulf Coast refineries to have access to heavy crude, there is a lot of activity. Now, until Pemex decides how they're going to fix paying vendors, there's going to be that lag still. We are starting to see increased activity, and the hope is that we'll start seeing something out of there.
We'll never be the magnitude that we had, but hope is we'll see something coming out of there. Again, there are some opportunities in Venezuela too that we're going to start pursuing that hopefully will benefit as well.
Got it. Thank you. Then one last question, just on capital allocation priorities. I see that you bought back a lot of shares. You authorized a new $75 million buyback, which is great. I think in the prior quarter, you had talked about increasing M&A opportunities this year, and I'm wondering if that's changed in your outlook, just given the higher degree of share buyback. Can you do both with the cash flow and the cash pile that you have?
Yeah. I think we can do both. You know, we tapped the brakes a little bit, John, until we get Performance Chemicals righted. We're starting to see a light at the end of that tunnel, and the hope is that after we get through Q2, where we'll see a similar quarter as we saw in Q1, that we start seeing those big improvements that we've anticipated in Q3 and Q4. Once we see that turnaround, and it's in actual numbers, not in just talk, but in actual numbers, I think you'll see us aggressively going after M&A. We haven't stopped. We just haven't found the right thing. We are continuously looking. You know, the hope is the right deal doesn't come around until Q3, when we see those numbers improve.
Is it fair to say that deal would be dependent on that facility getting fixed, or is that just something you're hoping to have as a bogey in terms of operations?
It's hoping. Yeah. It's hoping I have as a bogey.
Okay. Got it. Thank you.
You're welcome.
Thank you. Now we're going to take our next question. The question comes line of David Silver from Freedom Capital Markets. Your line is open. Please ask the question.
Hi, good morning. Thank you.
Go ahead, David.
Yeah, good morning. I would like to maybe kind of drill down just a little bit on Fuel Specialties. You know, according to my records, you know, both the revenues and especially operating income were kind of at, you know, all-time highs. More to the point, you know, rather than just isolating 1 period, I mean, you know, maybe 3 out of the last 4 quarters have really been, you know, exceptionally strong from a historical perspective. I know you kind of talk about this as being a very steady business but, you know, 10% volume growth this quarter and just the overall trend kind of points to maybe, I don't know, some share gains or some new products making an impact.
You know, maybe if you could just comment, not just on good results, but on, you know, record results and kind of consecutive periods of kind of above normal or above trend, I would say, growth and margin performance. Underneath, I mean, underlying this, what might be moving more positively than the historical trends, that, you know, might indicate?
Yeah, good question, David. I'll take that. You know, some of it has been market changes, market improvements, volume gains, price mix. There's been a little bit of variable in your question. The other that we've seen is that we've started to grow a lot of business in adjacent markets that are outside of fuels. Whether you're looking at polyethylene plants, propylene, et cetera. We've moved into other market segments that are an offshoot of Fuel Specialties. That's been a beneficial gain and nice margins in that area. They've done a really good job of putting together a strategy and a plan in place and sticking to it. As you know, that business is always extremely steady. I've been involved in that business from day one.
It was my business prior to being CEO of this company. I know this business extremely well. They've done a really good job running this business. They've created themselves opportunities. We've got a good product pipeline, and that's why we feel confident that we can continue to either, A, grow or sustain moving forward in this year and beyond. It's, it's a little bit of everything, which you'd like to see. You don't want to see one thing create all the positive. It's a little bit of everything that's created the positive. Now, you are going into a 2nd quarter. You always see a drop-off because of seasonality. You just have to remember that. You know, again, I think the sequential improvement has been very impressive, as you said.
If you don't mind, I'm just gonna follow up. You know, again, you know, from the perspective of, you know, very strong results. I mean, near term, I guess, you know, the diesel markets have been, you know, rattled a bit on the cost and maybe availability side. You know, various airlines are, you know, balking, I guess, or having trouble operating in the current environment. I mean, just from your perspective, I know diesel and jet are important to your Fuel Specialties, but, you know, how would you say, you know, what has been the strategy or the plan to kind of, you know, continue to operate or perform so well despite, you know, kind of objectively some meaningful near-term disruptions?
Yeah. Dave, I think it's diversification of portfolio within Fuel Specialties. Again, you know, we treat marine, bunker, jet, gasoline, diesel. We've gone to adjacent markets outside of core fuels and heavy fuels. It's the creativity within the organization and the diversification of the portfolio which will help us sustain kind of where we are today. Now, we are watching heavily what's going on with fuels. As you said, you see Spirit Airlines go down and others blaming it on fuel costs. Why they weren't hedging fuel costs is beyond me, but my only point there is we are watching demand destruction and see if it hits us. It has not as of yet. You know, the consumer is extremely strong still.
You know, usage is still strong, but we are watching it closely. Again, the diversification within the portfolio has always helped us overcome these chaotic markets.
Okay. Just one more kind of maybe bigger picture question. You know, when I think of, you know, the disruptions from the Persian Gulf and, you know, one or two other areas, I mean, I, you know, I do think, and you touched on this earlier, but I do think, you know, oil field in particular, but probably, you know, multiple areas do have, you know, objectively they're gonna have greater opportunities regardless of when and how the Persian Gulf situation plays out. I mean, people are just gonna wanna source differently. From your perspective, I mean, you know, I think you have multiple areas that could benefit, which you did discuss, but I'd like to maybe ask you about the resourcing.
In other words, you know, what would you have to do in Oilfield Services, for example, to take advantage of what we're seeing, you know, on a daily basis, which is a much greater interest in, you know, U.S. petroleum and petroleum products exports. You know, there probably are some other, you know, businesses. I'm just wondering, you know, do you have spare capacity now or do you need to really, you know, increase maybe either investments in capacity or investments in talent to kinda, you know, take full advantage?
You know, I think we're properly positioned and, you know, I think security supply is big on everybody's mind and we're well-positioned for security supply. You know, I think during chaotic times like this, innovation is gonna be on the forefront of everybody. If you're looking at, you know, similar technologies that come out of the Gulf based off of raw material, can you do something different in other markets that are sustainable long term with technology? Those are things that we're looking at and consistently and constantly bringing to the market. I think, you know, if you really look at when these market dynamics change like they are today, innovation security supply is on everybody's mind.
That's going to be our focus during these times, but as well as sustainability when things come back to normal, if and when they do. That's the key for our group, is to make sure that what we do today brings us sustainability in the following years moving forward.
Okay, great. I appreciate all the color. Thanks very much.
Thank you.
Thank you. The speakers are now for the questions for today. I would now like to hand the conference over to Patrick Williams for any close remarks.
Thank you all for joining us today, and thanks to all our shareholders, customers, and Innospec employees for your interest and support. Sorry, yeah. If you have any further questions about Innospec on matters discussed today, please give us a call. We look forward to meeting up with you again to discuss the second quarter 2026 results in August. Have a great day.
This concludes today's conference call. Thank you for participating. You may now all disconnect. Have a nice day.
Investor releaseQuarter not tagged2026-05-06This Fund Disclosed Selling $18 Million in Alphatec Last Quarter. The Stock Just Tanked 20% After Earnings
Motley Fool
This Fund Disclosed Selling $18 Million in Alphatec Last Quarter. The Stock Just Tanked 20% After Earnings
On May 5, 2026, Western Standard disclosed in an SEC filing that it sold 1,232,881 shares of Alphatec Holdings (NASDAQ:ATEC), an estimated $17.95 million trade based on quarterly average pricing. According to an SEC filing dated May 5, 2026, Western Standard reduced its holdings in Alphatec Holdings (NASDAQ:ATEC) by 1,232,881 shares during the first quarter. The estimated value of the shares sold was $17.95 million based on the mean unadjusted close for the quarter. The quarter-end value of the remaining stake reflects a $26.17 million decrease, a figure that includes both share sales and price changes. After this sale, the Alphatec Holdings position accounts for 0.13% of Western Standard's reported U.S. equity assets. Top holdings as of the filing: NYSE:GDOT: $39.79 million (20.9% of AUM) NYSE:CODI: $24.66 million (13.0% of AUM) NYSE:TFX: $22.11 million (11.6% of AUM) NASDAQ:IOSP: $16.56 million (8.7% of AUM) NYSE:OSG: $10.45 million (5.5% of AUM) As of May 4, 2026, Alphatec Holdings shares were priced at $10.33, down 13.8% over one year and underperforming the S&P 500 by 40.54 percentage points. However, shares plunged more than 20% to about $8.12 in after-hours trading on Tuesday following worse-than-expected results. Alphatec offers a portfolio of spinal surgery solutions including neural monitoring systems, minimally invasive access platforms, fixation systems, interbody implants, and biologics The firm generates revenue primarily through the sale of proprietary medical devices and biologics to hospitals and surgical centers, leveraging a direct sales force and independent distributors It serves orthopedic and neurosurgeons specializing in spinal disorders across the United States, with a focus on complex and degenerative spine procedures Alphatec Holdings is a U.S.-based medical technology company specializing in innovative surgical solutions for spinal disorders. The company pursues growth by expanding its differentiated product portfolio and investing in technologies that enhance surgical outcomes and patient safety. Its competitive edge stems from a focus on surgeon-driven innovation and a broad suite of proprietary systems tailored to complex spine procedures. The timing of this disclosure is interesting because it happened not long before Alphatec reported first-quarter results after Tuesday’s market close that very much disappointed investors. Re...
Investor releaseQuarter not tagged2026-04-30Analysts Estimate Innospec (IOSP) to Report a Decline in Earnings: What to Look Out for
Zacks
Analysts Estimate Innospec (IOSP) to Report a Decline in Earnings: What to Look Out for
The market expects Innospec (IOSP) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended March 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates. The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on May 7. On the other hand, if they miss, the stock may move lower. While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise. This specialty chemicals company is expected to post quarterly earnings of $1.02 per share in its upcoming report, which represents a year-over-year change of -28.2%. Revenues are expected to be $432.15 million, down 2% from the year-ago quarter. The consensus EPS estimate for the quarter has been revised 6.01% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts. Price, Consensus and EPS Surprise Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core. The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predict...
Investor releaseQuarter not tagged2026-04-28Will Innospec (IOSP) Beat Estimates Again in Its Next Earnings Report?
Zacks
Will Innospec (IOSP) Beat Estimates Again in Its Next Earnings Report?
Looking for a stock that has been consistently beating earnings estimates and might be well positioned to keep the streak alive in its next quarterly report? Innospec (IOSP), which belongs to the Zacks Chemical - Diversified industry, could be a great candidate to consider. When looking at the last two reports, this specialty chemicals company has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 13.89%, on average, in the last two quarters. For the last reported quarter, Innospec came out with earnings of $1.5 per share versus the Zacks Consensus Estimate of $1.26 per share, representing a surprise of 19.05%. For the previous quarter, the company was expected to post earnings of $1.03 per share and it actually produced earnings of $1.12 per share, delivering a surprise of 8.74%. For Innospec, estimates have been trending higher, thanks in part to this earnings surprise history. And when you look at the stock's positive Zacks Earnings ESP (Expected Surprise Prediction), it's a great indicator of a future earnings beat, especially when combined with its solid Zacks Rank. Our research shows that stocks with the combination of a positive Earnings ESP and a Zacks Rank #3 (Hold) or better produce a positive surprise nearly 70% of the time. In other words, if you have 10 stocks with this combination, the number of stocks that beat the consensus estimate could be as high as seven. The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a version of the Zacks Consensus whose definition is related to change. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier. Innospec currently has an Earnings ESP of +2.46%, which suggests that analysts have recently become bullish on the company's earnings prospects. This positive Earnings ESP when combined with the stock's Zacks Rank #3 (Hold) indicates that another beat is possibly around the corner. We expect the company's next earnings report to be released on May 7, 2026. Investors should note, however, that a negative Earnings ESP reading is not indicative of an earnings miss, but a negative value does reduce the predic...
Investor releaseQuarter not tagged2026-04-20Innospec (IOSP) Q4 2024 Earnings Transcript
Motley Fool
Innospec (IOSP) Q4 2024 Earnings Transcript
Image source: The Motley Fool. Wednesday, February 19, 2025 at 9 a.m. ET President & Chief Executive Officer — Patrick S. Williams Executive Vice President & Chief Financial Officer — Ian P. Cleminson Patrick Williams: Thank you, David, and welcome, everyone, to Innospec fourth quarter and full year 2024 conference call. This was another good quarter for Innospec as we exceeded earnings expectations despite the reduced Oilfield Services activity in Latin America. In Performance Chemicals, we delivered double-digit operating income growth over the fourth quarter last year driven by improved sales and margins. We have a balanced pipeline of growth opportunities across our global personal care, home care, agriculture, construction, and other industrial markets. In addition, the integration and performance of our recent QGP acquisition in Brazil is proceeding to plan and is supporting not only Performance Chemicals but also Fuel Specialties growth opportunities in the region. Moving to 2025, we continue to target operating income and margin improvement to levels consistent with full year 2022. In Fuel Specialties, operating income increased 7% over the same quarter last year, and operating margin improved to just below our target of 19% to 21%. We remain focused on further margin improvement in parallel with top-line growth. With our industry-leading innovation and customer service capabilities, we are well-positioned to continue advancing our global customers' initiatives. Our technology will continue to focus on cleaner fuels, lowering emissions, and improving efficiency in traditional, renewable, and non-fuel applications. In Oilfield Services, as expected, results were similar to the third quarter of no recover in Latin America production chemical activity. We currently do not expect this activity to resume in the near term. In 2025, we remain focused on continuing to drive sequential quarterly improvements in our core businesses, including U.S. completions and production, DRA in the Middle East. Now I will turn the call to Ian Cleminson, who will review our financial results in more detail. Then I will return with some concluding comments. After that, Ian, I will take your questions. Ian? Ian Cleminson: Thanks, Patrick. Turning to Slide 7 in the presentation, the company's total revenues for the fourth quarter were $466.8 million, a 6% decrease from $494.7...

